tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BOLT Stock Latest News

SunPower, Accenture downgraded: Wall Street’s top analyst calls
The FlySunPower, Accenture downgraded: Wall Street’s top analyst calls
3M ago
PK
SE
Bolt Biotherapeutics downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Bolt Biotherapeutics downgraded to Hold from Buy at JonesResearch
3M ago
BOLT
Bolt Biotherapeutics ceases BDC-1001 development, cuts 50% of staff
PremiumThe Fly
Bolt Biotherapeutics ceases BDC-1001 development, cuts 50% of staff
3M ago
BOLT
Bolt Biotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Bolt Biotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
3M ago
BOLT
Bolt Biotherapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Bolt Biotherapeutics downgraded to Market Perform from Outperform at Leerink
3M ago
BOLT
Guggenheim downgrades Bolt Biotherapeutics on lead candidate discontinuation
PremiumThe FlyGuggenheim downgrades Bolt Biotherapeutics on lead candidate discontinuation
3M ago
BOLT
Bolt Biotherapeutics downgraded to Hold from Buy at Stifel
PremiumThe Fly
Bolt Biotherapeutics downgraded to Hold from Buy at Stifel
3M ago
BOLT
Bolt Biotherapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Bolt Biotherapeutics downgraded to Neutral from Buy at Guggenheim
3M ago
BOLT
Bolt Biotherapeutics reports Q1 EPS (28c), consensus (51c)
PremiumThe Fly
Bolt Biotherapeutics reports Q1 EPS (28c), consensus (51c)
3M ago
BOLT
Bolt Biotherapeutics Realigns Operations and Leadership Team
PremiumCompany Announcements
Bolt Biotherapeutics Realigns Operations and Leadership Team
3M ago
8K
BOLT
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
4M ago
BOLT
Bolt Biotherapeutics reports Q4 EPS (47c), consensus (48c)
PremiumThe Fly
Bolt Biotherapeutics reports Q4 EPS (47c), consensus (48c)
4M ago
BOLT
Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
PremiumPress ReleasesBolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
5M ago
BOLT
Bolt Biotherapeutics enrolls first patient in Phase 2 study of BDC-1001
PremiumThe Fly
Bolt Biotherapeutics enrolls first patient in Phase 2 study of BDC-1001
8M ago
BOLT
Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
PremiumPress Releases
Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
8M ago
BOLT
Bolt Biotherapeutics sees cash funding operations, milestones through 2025
PremiumThe Fly
Bolt Biotherapeutics sees cash funding operations, milestones through 2025
9M ago
BOLT
Bolt Biotherapeutics reports Q3 EPS (43c), consensus (49c)
PremiumThe Fly
Bolt Biotherapeutics reports Q3 EPS (43c), consensus (49c)
9M ago
BOLT
Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
9M ago
BOLT
Bolt presents updated clinical data from Phase 1 trial of BDC-1002
PremiumThe Fly
Bolt presents updated clinical data from Phase 1 trial of BDC-1002
9M ago
BOLT
Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress
PremiumPress ReleasesBolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress
9M ago
BOLT
Bolt Biotherapeutics reports first patient dosed in Phase 1/2 study of BDC-3042
PremiumThe Fly
Bolt Biotherapeutics reports first patient dosed in Phase 1/2 study of BDC-3042
10M ago
BOLT
Bolt Biotherapeutics Announces First Patient Dosed in Phase 1/2 Study of BDC-3042 in Patients with Advanced Cancers
PremiumPress Releases
Bolt Biotherapeutics Announces First Patient Dosed in Phase 1/2 Study of BDC-3042 in Patients with Advanced Cancers
10M ago
BOLT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >